Catalyst Wire Dossier Catalyst Wire Dossier

RIVELSA

LEVONORGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL · Teva Pharmaceuticals USA, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for RIVELSA, covering 2013-03-28 to 2022-08-04. Get the full timeline:

Most recent: FDA Approved: RIVELSA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

See pricing